Fire disrupts production at Alembic joint-venture generics plant in Algeria

Alembic reports fire disruption at Algerian JV generics plant.

A fire disrupted production last week at an Algerian-based generics plant—operated under a joint venture between Alembic Mami and local pharma Adwiya Mami—according to Indian drugmaker Alembic Pharma. 

Alembic made the announcement in a filing (PDF) with the Bombay Stock Exchange.

“The cause of (the) accident and the extend of damage is being investigated and assessed,” the company said in the filing. “Though the fixed assets and inventories are covered under insurance policies and we do not expect a major adverse impact, we (do) expect a disruption in operation (until) the plant is put back on stream.”


Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

The company said no one was injured in the fire, which was brought under control.

The joint venture that was formed in 2014 is Alembic’s first entry outside the Indian market. The plant in Constantine opened in 2015.

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

As flights from China contract and prices double, the logistics of getting products out of China is a major challenge. 

A group of drugmakers and others say some federal policies to fight COVID-19 are it making more expensive and harder to get some drugs.